- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Enfortumab vedotin
Total 390 results
-
SethiMerck Sharp & Dohme LLCRecruitingT-Cell LymphomaUnited States
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
Seagen Inc.Merck Sharp & Dohme LLC; GenmabRecruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Exocrine Pancreatic Cancer | Carcinoma, Squamous Cell of Head and NeckUnited States, Canada, France, Germany, Italy, Spain, United Kingdom, Puerto Rico
-
Seagen Inc.CompletedHodgkin DiseaseUnited States
-
The Lymphoma Academic Research OrganisationCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaFrance, Belgium
-
Federal Research Institute of Pediatric Hematology...RecruitingHodgkin's LymphomaRussian Federation
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Arbeitsgemeinschaft medikamentoese TumortherapieTerminatedALK+ Anaplastic Large Cell LymphomaAustria
-
Shanghai Zhongshan HospitalNot yet recruitingColorectal Neoplasms
-
Fondazione Italiana Linfomi ONLUSCompleted
-
RemeGen Co., Ltd.RecruitingUrothelial Carcinoma | HER2-expressingChina
-
Lawson Health Research InstituteSeagen Inc.RecruitingDiffuse Cutaneous Systemic SclerosisCanada
-
Washington University School of MedicineCelgene; Seagen Inc.CompletedLymphoma, Large B-Cell, DiffuseUnited States
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
RemeGen Co., Ltd.RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
Jason Robert GotlibSeagen Inc.CompletedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Seagen Inc.Terminated
-
Nabil AdraTerminatedNonseminomatous Germ Cell Tumor | Testis Cancer | Testicular Cancer | Embryonal Carcinoma | Germ Cell TumorsUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
M.D. Anderson Cancer CenterTerminated
-
Eric Bernicker, MDMillennium Pharmaceuticals, Inc.; The Methodist Hospital Research InstituteWithdrawnCD30-positive Lymphoma | CD30-positive Solid TumorUnited States
-
GE HealthcareCompletedMild Cognitive Impairment | Alzheimer's Disease
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States
-
New York Medical CollegeRecruitingFollicular Lymphoma | B-cell Lymphoma | Hodgkin Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Richter Syndrome | Transformed Non-Hodgkin LymphomaUnited States
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Southwest Oncology Group; North Central Cancer...CompletedBreast Cancer | OsteoporosisCanada
-
MerLion Pharmaceuticals GmbHCompleted
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingUrothelial CarcinomaUnited States, Canada, United Kingdom, Japan, Australia, Argentina, Chile, Israel
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung CancerUnited States, Canada
-
Guoxin LiNot yet recruiting
-
University of Kansas Medical CenterSeagen Inc.Recruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruiting
-
CuraGen CorporationCompletedBreast CancerUnited States
-
Fondazione MichelangeloFondazione IRCCS Istituto Nazionale dei Tumori, Milano; Millennium Pharmaceuticals...CompletedGerm Cell CancerItaly
-
CuraGen CorporationCompletedUnresectable Stage III or Stage IV MelanomaUnited States
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
Bernstein, Jonathan A., M.D.Dyax Corp.Unknown
-
Yan Zhang, MDPeking University First Hospital; Chinese PLA General Hospital; Peking University...Recruiting
-
Miltenyi Biomedicine GmbHICON plcRecruitingDiffuse Large B-cell LymphomaSpain, Germany, Netherlands, Belgium, France, Czechia, Austria, Lithuania, Poland, Sweden, Hungary, Italy
-
Peng LiuRecruitingDiffuse Large B Cell LymphomaChina
-
Hospital Regional de Alta Especialidad del BajioUniversidad de GuanajuatoRecruitingHodgkin Lymphoma | Refractory Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultMexico
-
Hoffmann-La RocheCompletedRelapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell LymphomaUnited States, Spain, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedHodgkin LymphomaPoland, Spain, Malaysia, Turkey, Germany, Czechia, Thailand
-
Fondazione Italiana Linfomi ONLUSCompletedPrimary Mediastinal Large B Cell LymphomaItaly
-
University Hospital Inselspital, BerneMundipharma Medical CompanyRecruiting
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
Hoffmann-La RocheActive, not recruitingDiffuse Large B-Cell LymphomaUnited States, United Kingdom, Korea, Republic of, Finland, Brazil, China, Mexico, Canada, Germany, India, Turkey, Greece, Italy, Spain, France, Ireland
-
Seagen Inc.TerminatedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States
-
Seagen Inc.RemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Triple Negative Breast Neoplasms | Gastroesophageal Junction Adenocarcinoma | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States